Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Cytokinetics Stock Price (Quote) NASDAQ:CYTK
$39.85 ( 0.23% ) Monday, 23rd May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $33.60 | $44.85 | Monday, 23rd May 2022 CYTK stock ended at $39.85. This is 0.23% more than the trading day before Friday, 20th May 2022. During the day the stock fluctuated 5.20% from a day low at $38.63 to a day high of $40.64. |
| 90 days | $30.27 | $44.85 | |
| 52 weeks | $17.72 | $47.90 |
Historical Cytokinetics prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-23 | $40.43 | $40.64 | $38.63 | $39.85 | 718 133 |
| 2022-05-20 | $39.23 | $39.85 | $38.03 | $39.76 | 710 792 |
| 2022-05-19 | $38.16 | $39.17 | $36.81 | $38.79 | 1 424 136 |
| 2022-05-18 | $41.02 | $42.16 | $38.45 | $38.65 | 1 189 106 |
| 2022-05-17 | $42.43 | $43.60 | $41.60 | $42.15 | 1 125 626 |
| 2022-05-16 | $42.95 | $44.85 | $41.14 | $43.40 | 939 011 |
| 2022-05-13 | $38.85 | $42.29 | $38.85 | $42.01 | 1 209 213 |
| 2022-05-12 | $36.64 | $39.38 | $35.88 | $38.35 | 699 723 |
| 2022-05-11 | $37.54 | $38.98 | $36.80 | $36.90 | 927 996 |
| 2022-05-10 | $36.56 | $38.75 | $36.20 | $37.89 | 962 273 |
| 2022-05-09 | $37.06 | $37.69 | $34.50 | $34.97 | 1 241 741 |
| 2022-05-06 | $39.40 | $39.77 | $37.22 | $38.06 | 858 965 |
| 2022-05-05 | $41.33 | $42.37 | $39.31 | $40.34 | 1 190 158 |
| 2022-05-04 | $40.30 | $41.38 | $37.95 | $41.03 | 869 562 |
| 2022-05-03 | $40.10 | $40.75 | $39.25 | $40.00 | 644 075 |
| 2022-05-02 | $40.04 | $41.26 | $37.80 | $39.93 | 1 538 048 |
| 2022-04-29 | $34.87 | $40.55 | $34.82 | $39.87 | 2 344 643 |
| 2022-04-28 | $35.35 | $35.97 | $33.60 | $35.75 | 1 032 733 |
| 2022-04-27 | $33.94 | $35.13 | $33.94 | $34.69 | 616 352 |
| 2022-04-26 | $36.18 | $36.18 | $33.79 | $33.93 | 1 133 800 |
| 2022-04-25 | $35.89 | $37.01 | $34.97 | $36.50 | 842 066 |
| 2022-04-22 | $36.32 | $36.95 | $35.79 | $35.93 | 356 388 |
| 2022-04-21 | $37.97 | $38.52 | $36.30 | $36.60 | 686 600 |
| 2022-04-20 | $38.17 | $38.70 | $37.42 | $37.81 | 538 400 |
| 2022-04-19 | $38.25 | $38.76 | $37.76 | $37.93 | 1 012 000 |
| 2022-04-18 | $39.37 | $39.37 | $37.94 | $38.25 | 648 200 |
| 2022-04-14 | $40.94 | $41.16 | $39.41 | $39.59 | 158 718 |
| 2022-04-13 | $40.72 | $41.58 | $40.55 | $40.97 | 641 082 |
| 2022-04-12 | $41.69 | $42.78 | $40.47 | $40.78 | 453 303 |
| 2022-04-11 | $41.26 | $42.54 | $40.56 | $41.07 | 997 309 |
| 2022-04-08 | $42.75 | $43.29 | $41.38 | $41.63 | 585 487 |
| 2022-04-07 | $42.17 | $43.53 | $41.98 | $43.19 | 1 247 200 |
| 2022-04-06 | $39.80 | $43.48 | $39.51 | $42.54 | 1 309 600 |
| 2022-04-05 | $40.35 | $42.16 | $39.97 | $40.35 | 955 900 |
| 2022-04-04 | $38.50 | $40.13 | $38.19 | $40.04 | 1 119 500 |
| 2022-04-01 | $36.82 | $38.50 | $36.80 | $38.36 | 694 768 |
| 2022-03-31 | $36.75 | $37.69 | $36.33 | $36.79 | 378 639 |
| 2022-03-30 | $38.32 | $38.66 | $36.40 | $36.53 | 444 721 |
| 2022-03-29 | $37.19 | $38.45 | $36.69 | $38.42 | 601 100 |
| 2022-03-28 | $36.51 | $37.28 | $35.67 | $36.76 | 344 400 |
| 2022-03-25 | $37.91 | $37.91 | $35.96 | $36.47 | 508 900 |
| 2022-03-24 | $37.24 | $38.03 | $36.73 | $37.67 | 520 100 |
| 2022-03-23 | $35.92 | $37.55 | $35.56 | $37.18 | 767 900 |
| 2022-03-22 | $35.55 | $36.48 | $35.54 | $36.30 | 1 113 992 |
| 2022-03-21 | $37.25 | $37.29 | $35.32 | $35.57 | 972 975 |
| 2022-03-18 | $37.59 | $38.34 | $36.63 | $37.32 | 1 663 806 |
| 2022-03-17 | $34.40 | $37.22 | $34.28 | $37.05 | 971 200 |
| 2022-03-16 | $34.17 | $34.81 | $33.10 | $34.72 | 1 312 700 |
| 2022-03-15 | $33.36 | $34.74 | $33.36 | $33.94 | 798 600 |
| 2022-03-14 | $37.40 | $37.51 | $34.50 | $34.69 | 1 211 700 |
Cytokinetics, Incorporated, a late stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. It is developing tirasemtiv, a fast skeletal muscle troponin activator that is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis; CK-2127107, which is in Phase II clinical trials for... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
